Cadwalader allows sharing content.
Email to a friend or colleague:
From
To
Subject
Email Cadwalader advised Corindus Vascular Robotics (NYSE American: CVRS) in its definitive merger agreement to be acquired by Siemens Healthineers AG in a transaction valued at $1.1 billion. https://www.cadwalader.com/news/news-release/cadwalader-advises-corindus-vascular-robotics-in-its-definitive-agreement-to-be-acquired-by-siemens-healthineers-ag